NEW YORK, April 28, 2025--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare ...
NEW HOPE, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to ...
While there have been many advances made in the breast cancer treatment paradigm, radiation therapy remains a mainstay in early stage disease, according to Dr. Joseph Panoff. At the CURE® Educated ...
While there is still no cure for multiple myeloma, CAR-T cell therapy offers patients with previously treated myeloma “unprecedented” outcomes, according to Dr. Surbhi Sidana, assistant professor of ...
Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...
YANTAI, China, June 2, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results